Jenoptik AG

XTRA:JEN Lagerbericht

Marktkapitalisierung: €2.5b

Jenoptik Zukünftiges Wachstum

Future Kriterienprüfungen 3/6

Jenoptik wird ein jährliches Gewinn- und Umsatzwachstum von 18.1% bzw. 7.1% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 17.7% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 11.3% betragen.

Wichtige Informationen

18.1%

Wachstumsrate der Gewinne

17.73%

EPS-Wachstumsrate

Electronic Gewinnwachstum35.2%
Wachstumsrate der Einnahmen7.1%
Zukünftige Eigenkapitalrendite11.34%
Analystenabdeckung

Good

Zuletzt aktualisiert01 Jun 2026

Jüngste Aktualisierungen zum künftigen Wachstum

Analyseartikel May 16

Jenoptik AG Just Missed EPS By 16%: Here's What Analysts Think Will Happen Next

It's been a good week for Jenoptik AG ( ETR:JEN ) shareholders, because the company has just released its latest...
Analyseartikel Nov 15

Earnings Beat: Jenoptik AG Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Jenoptik AG ( ETR:JEN ) shareholders are probably feeling a little disappointed, since its shares fell 3.2% to €21.82...

Recent updates

Narrativ-Update Jun 08

JEN: Future Returns Will Rely On Delivering Against Richer P E Expectations

Analysts have lifted the Jenoptik fair value estimate from €24.00 to €29.50, reflecting higher published price targets from several banks and updated assumptions for growth, profitability and future P/E. Analyst Commentary Street research on Jenoptik is mixed, with some firms lifting price targets and others turning more cautious on the stock.
Narrativ-Update May 25

JEN: Future P/E Repricing Will Pressure Fair Value Despite Recent Optimism

The analyst price target for Jenoptik has been raised from about €34.81 to about €38.31. Analysts point to refreshed views on growth, margins, and a higher assumed future P/E multiple, following several recent target increases and rating changes on the stock.
Narrativ-Update May 06

JEN: Fair Value View Will Hinge On Mixed P/E And Margin Expectations

Analysts have raised the fair value estimate for Jenoptik from €28.50 to approximately €34.81, reflecting updated assumptions on revenue growth, profit margins, and future P/E, along with recent mixed rating and price target revisions from several banks. Analyst Commentary Bullish Takeaways Bullish analysts have raised price targets for Jenoptik, which points to greater confidence in the company’s ability to support a higher fair value over time if it executes as expected.
Narrativ-Update Apr 21

JEN: Future Returns Will Depend On Execution Against Higher P E Assumptions

Analysts have raised their price targets on Jenoptik by €1 to €6, citing slightly adjusted assumptions for revenue growth, profit margins and future P/E multiples as the key factors behind the revised estimates. Analyst Commentary Recent research updates on Jenoptik point to a mixed backdrop, with higher price targets and rating upgrades sitting alongside more cautious voices that are focused on execution risk and valuation sensitivity.
Narrativ-Update Apr 06

JEN: Future Returns Will Depend On Cautious P/E Assumptions Despite Recent Upgrade

Analysts have nudged their Jenoptik price targets higher, with recent increases of €1 and €6. These changes help to support a slightly lower P/E assumption and a modestly stronger revenue growth outlook in the updated model.
Narrativ-Update Mar 23

JEN: Higher P/E Confidence Will Support Appeal Despite Margin Reset

Analysts have raised their fair value estimate for Jenoptik from €32.00 to €33.00, reflecting updated assumptions on revenue growth, profit margins, and future P/E, as well as recent supportive Street research. Analyst Commentary Recent Street research points to a more constructive tone around Jenoptik, with bullish analysts highlighting factors they see as supportive of the revised €33.00 fair value estimate.
Narrativ-Update Mar 09

JEN: Fair Value View Will Rely On Margins And P/E Holding Firm

Analysts have raised their price target on Jenoptik from €25.56 to €28.50. They cite adjustments to fair value estimates, discount rate assumptions, revenue growth expectations, profit margin outlook and future P/E levels as the reasons for the change.
Narrativ-Update Feb 23

JEN: Future Returns Will Depend On Uncertain Margin And P/E Assumptions

Narrative Update on Jenoptik Analysts have lifted their fair value estimate for Jenoptik from €21.50 to €24.00. This reflects slightly adjusted assumptions around discount rates, revenue growth, profit margins and future P/E multiples in recent research updates.
Analyseartikel Feb 14

We Think Jenoptik (ETR:JEN) Is Taking Some Risk With Its Debt

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
Narrativ-Update Feb 09

JEN: Upgraded Outlook Will Rely On Optimistic Margin And P/E Assumptions

Analysts have nudged their fair value target for Jenoptik slightly higher to €21.50, citing updated assumptions for discount rate, revenue growth, profit margin and future P/E that reflect the latest Deutsche Bank research upgrade and related Street analysis. Analyst Commentary Recent research points to a more cautious tone around Jenoptik, even with fair value estimates now centered around €21.50.
Analyseartikel Jan 29

Investors Appear Satisfied With Jenoptik AG's (ETR:JEN) Prospects As Shares Rocket 25%

Jenoptik AG ( ETR:JEN ) shareholders have had their patience rewarded with a 25% share price jump in the last month...
Narrativ-Update Jan 26

JEN: Multi Year Outlook Will Balance Leadership Transition And Earnings Multiple

Analysts have reaffirmed their price target on Jenoptik at €21.50, reflecting updated views on the company’s discount rate, revenue growth assumptions, profit margin outlook, and expected future P/E multiple. What's in the News Jenoptik's supervisory board announced that President & CEO Dr. Stefan Traeger will step down from the Executive Board on February 15, 2026, after nearly nine years in the role, and will leave Jenoptik AG by mutual agreement.
Narrativ-Update Jan 11

JEN: Higher Margin Outlook Will Support Appeal Despite Leadership Transition

Analysts have trimmed their fair value estimate for Jenoptik from €34.22 to €32.00, citing updated assumptions for slightly lower revenue growth, a higher profit margin and a reduced future P/E multiple. What's in the News The supervisory board announced that Dr. Stefan Traeger will step down from the Executive Board on February 15, 2026 and leave Jenoptik AG by mutual agreement after nearly nine years as President & CEO (Key Developments).
Analyseartikel Jan 03

What Does Jenoptik AG's (ETR:JEN) Share Price Indicate?

Jenoptik AG ( ETR:JEN ), is not the largest company out there, but it saw a double-digit share price rise of over 10...
Narrativ-Update Dec 26

JEN: Multi Year Revenue Outlook Will Support Stronger Future Earnings Multiple

Analysts have raised their price target on Jenoptik from €18.50 to €21.50, reflecting improved expectations for multi year revenue growth, slightly higher profit margins, and a richer future earnings multiple. What's in the News The supervisory board announced that President and CEO Dr. Stefan Traeger will step down from the Executive Board on February 15, 2026, and will leave Jenoptik AG by mutual agreement after nearly nine years in the role (company announcement) Valuation Changes The fair value estimate has risen moderately from €18.50 to €21.50, reflecting a more optimistic outlook on Jenoptik's intrinsic worth.
Narrativ-Update Dec 12

JEN: Stable Margins And Leadership Transition Will Support Future Upside Potential

Analysts have marginally increased their price target on Jenoptik to approximately $25.56. This reflects slightly higher assumptions for the company’s discount rate and future price to earnings multiple, while maintaining stable growth and margin expectations.
Analyseartikel Dec 01

An Intrinsic Calculation For Jenoptik AG (ETR:JEN) Suggests It's 49% Undervalued

Key Insights Using the 2 Stage Free Cash Flow to Equity, Jenoptik fair value estimate is €39.06 Jenoptik's €19.74 share...
Narrativ-Update Nov 27

JEN: Modest Profit Margin Increase Will Drive Upside Potential

Analysts have raised their price target on Jenoptik slightly, increasing it from €25.44 to €25.56. They cited refinements in their financial models based on modest improvements in the company’s valuation metrics and outlook.
Narrativ-Update Nov 13

JEN: Revenue Gains And Profit Margin Improvement Will Support Upside Potential

Analysts have increased their fair value estimate for Jenoptik from €24.46 to €25.44. This change reflects expectations of higher revenue growth and improved profit margins, even though the discount rate is slightly lower.
Analyseartikel Oct 04

Cautious Investors Not Rewarding Jenoptik AG's (ETR:JEN) Performance Completely

With a price-to-earnings (or "P/E") ratio of 14.3x Jenoptik AG ( ETR:JEN ) may be sending bullish signals at the...
Narrativ-Update Sep 12

Global Semiconductor Investment Will Advance Photonics And Mobility Expansion

The downward revision in Jenoptik’s consensus price target reflects softer revenue growth forecasts, with fair value decreasing from €25.12 to €24.46. What's in the News Jenoptik AG removed from Germany MDAX Index (Performance).
Analyseartikel Aug 30

An Intrinsic Calculation For Jenoptik AG (ETR:JEN) Suggests It's 49% Undervalued

Key Insights The projected fair value for Jenoptik is €33.48 based on 2 Stage Free Cash Flow to Equity Jenoptik's...
Analyseartikel Jul 23

Does Jenoptik (ETR:JEN) Have A Healthy Balance Sheet?

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
Analyseartikel May 16

Jenoptik AG Just Missed EPS By 16%: Here's What Analysts Think Will Happen Next

It's been a good week for Jenoptik AG ( ETR:JEN ) shareholders, because the company has just released its latest...
Analyseartikel Apr 30

Jenoptik (ETR:JEN) Is Paying Out A Larger Dividend Than Last Year

Jenoptik AG ( ETR:JEN ) has announced that it will be increasing its dividend from last year's comparable payment on...
Analyseartikel Apr 20

Are Investors Undervaluing Jenoptik AG (ETR:JEN) By 34%?

Key Insights Using the 2 Stage Free Cash Flow to Equity, Jenoptik fair value estimate is €24.74 Jenoptik's €16.45 share...
Analyseartikel Apr 05

Benign Growth For Jenoptik AG (ETR:JEN) Underpins Stock's 34% Plummet

Jenoptik AG ( ETR:JEN ) shareholders that were waiting for something to happen have been dealt a blow with a 34% share...
Analyseartikel Feb 27

At €23.20, Is Jenoptik AG (ETR:JEN) Worth Looking At Closely?

Jenoptik AG ( ETR:JEN ), might not be a large cap stock, but it saw a double-digit share price rise of over 10% in the...
User avatar
Neues Narrativ Feb 22

Investments In Dresden Facility And Diversification Will Support Future Performance

Strategic investments in semiconductor capacity and sales channels bolster future growth, helping offset market volatility and enhance revenue potential.
Analyseartikel Jan 13

Here's Why Jenoptik (ETR:JEN) Can Manage Its Debt Responsibly

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
Analyseartikel Nov 15

Earnings Beat: Jenoptik AG Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Jenoptik AG ( ETR:JEN ) shareholders are probably feeling a little disappointed, since its shares fell 3.2% to €21.82...
Analyseartikel Nov 14

Jenoptik AG's (ETR:JEN) 28% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/ERatio

Jenoptik AG ( ETR:JEN ) shareholders that were waiting for something to happen have been dealt a blow with a 28% share...
Analyseartikel Oct 14

Is Jenoptik AG (ETR:JEN) Trading At A 47% Discount?

Key Insights The projected fair value for Jenoptik is €54.80 based on 2 Stage Free Cash Flow to Equity Current share...
Analyseartikel Sep 28

Is There Now An Opportunity In Jenoptik AG (ETR:JEN)?

While Jenoptik AG ( ETR:JEN ) might not have the largest market cap around , it saw a double-digit share price rise of...
Analyseartikel Aug 15

Market Participants Recognise Jenoptik AG's (ETR:JEN) Earnings

When close to half the companies in Germany have price-to-earnings ratios (or "P/E's") below 17x, you may consider...
Analyseartikel Jun 12

Here's Why Shareholders May Want To Be Cautious With Increasing Jenoptik AG's (ETR:JEN) CEO Pay Packet

Key Insights Jenoptik will host its Annual General Meeting on 18th of June CEO Stefan Traeger's total compensation...
Analyseartikel May 30

Does Jenoptik (ETR:JEN) Have A Healthy Balance Sheet?

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it might be obvious that you need to...
Analyseartikel Apr 25

Jenoptik (ETR:JEN) Will Pay A Larger Dividend Than Last Year At €0.35

The board of Jenoptik AG ( ETR:JEN ) has announced that it will be paying its dividend of €0.35 on the 21st of June, an...
Analyseartikel Apr 15

Jenoptik AG's (ETR:JEN) P/E Is On The Mark

When close to half the companies in Germany have price-to-earnings ratios (or "P/E's") below 17x, you may consider...
Analyseartikel Mar 30

Jenoptik's (ETR:JEN) Upcoming Dividend Will Be Larger Than Last Year's

Jenoptik AG ( ETR:JEN ) has announced that it will be increasing its periodic dividend on the 21st of June to €0.35...
Analyseartikel Mar 22

At €30.04, Is Jenoptik AG (ETR:JEN) Worth Looking At Closely?

While Jenoptik AG ( ETR:JEN ) might not have the largest market cap around , it saw a double-digit share price rise of...
Analyseartikel Jan 07

Getting In Cheap On Jenoptik AG (ETR:JEN) Might Be Difficult

When close to half the companies in Germany have price-to-earnings ratios (or "P/E's") below 16x, you may consider...
Analyseartikel Dec 20

Is Jenoptik (ETR:JEN) A Risky Investment?

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
Analyseartikel Dec 05

Why Jenoptik AG (ETR:JEN) Could Be Worth Watching

While Jenoptik AG ( ETR:JEN ) might not be the most widely known stock at the moment, it saw a significant share price...
Analyseartikel Sep 01

Is It Too Late To Consider Buying Jenoptik AG (ETR:JEN)?

Jenoptik AG ( ETR:JEN ), might not be a large cap stock, but it saw significant share price movement during recent...
Analyseartikel Aug 11

Is There An Opportunity With Jenoptik AG's (ETR:JEN) 49% Undervaluation?

Key Insights The projected fair value for Jenoptik is €53.53 based on 2 Stage Free Cash Flow to Equity Jenoptik's...
Analyseartikel Jul 25

Jenoptik (ETR:JEN) Has A Pretty Healthy Balance Sheet

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
Analyseartikel May 07

Jenoptik (ETR:JEN) Will Pay A Larger Dividend Than Last Year At €0.30

Jenoptik AG ( ETR:JEN ) has announced that it will be increasing its dividend from last year's comparable payment on...
Analyseartikel Apr 04

We Think Jenoptik (ETR:JEN) Can Stay On Top Of Its Debt

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...

Gewinn- und Umsatzwachstumsprognosen

XTRA:JEN - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (EUR Millions)
DatumUmsatzGewinneFreier CashflowBargeld aus operativen TätigkeitenDurchschn. Anz. Analysten
12/31/20281,2981391202019
12/31/20271,2211221091879
12/31/20261,1311011021819
3/31/20261,04476114174N/A
12/31/20251,04669123196N/A
9/30/20251,0546892176N/A
6/30/20251,0737369164N/A
3/31/20251,1038580180N/A
12/31/20241,1169174167N/A
9/30/20241,11284100190N/A
6/30/20241,10280102184N/A
3/31/20241,0887669155N/A
12/31/20231,0667379167N/A
9/30/20231,0517072154N/A
6/30/20231,0386869152N/A
3/31/20231,0067087170N/A
12/31/20229816263143N/A
9/30/20229297556130N/A
6/30/20228698148113N/A
3/31/2022809913892N/A
12/31/2021751915298N/A
9/30/20216306956101N/A
6/30/2021616584789N/A
3/31/2021602374887N/A
12/31/2020615334690N/A
9/30/20207654869113N/A
6/30/20208015494143N/A
3/31/20208365784136N/A
12/31/201985568N/A109N/A
9/30/201983778N/A90N/A
6/30/201983378N/A91N/A
3/31/201982982N/A118N/A
12/31/201883588N/A135N/A
9/30/201881482N/A119N/A
6/30/201878483N/A97N/A
3/31/201877480N/A95N/A
12/31/201774873N/A96N/A
9/30/201771962N/A94N/A
6/30/201770655N/A107N/A
3/31/201769056N/A103N/A
12/31/201668554N/A100N/A
9/30/201667451N/A108N/A
6/30/201667951N/A102N/A
3/31/201668148N/A101N/A
12/31/201566949N/A85N/A
9/30/201565846N/A69N/A
6/30/201562340N/A72N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: JENDas prognostizierte Gewinnwachstum (18.1% pro Jahr) liegt über der Sparquote (1.9%).

Ertrag vs. Markt: JENDie Erträge des Unternehmens (18.1% pro Jahr) werden voraussichtlich schneller wachsen als der Markt German (17.1% pro Jahr).

Hohe Wachstumserträge: JENDie Erträge des Unternehmens werden voraussichtlich steigen, jedoch nicht deutlich.

Einnahmen vs. Markt: JENDie Einnahmen des Unternehmens (7.1% pro Jahr) werden voraussichtlich schneller wachsen als der Markt German (6.7% pro Jahr).

Hohe Wachstumseinnahmen: JENDie Einnahmen des Unternehmens (7.1% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.


Wachstumsprognosen für den Gewinn je Aktie


Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: JENDie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (11.3%).


Wachstumsunternehmen entdecken

Unternehmensanalyse und Finanzdaten Status

DatenZuletzt aktualisiert (UTC-Zeit)
Unternehmensanalyse2026/06/19 05:33
Aktienkurs zum Tagesende2026/06/19 00:00
Gewinne2026/03/31
Jährliche Einnahmen2025/12/31

Datenquellen

Die in unserer Unternehmensanalyse verwendeten Daten stammen von S&P Global Market Intelligence LLC. Die folgenden Daten werden in unserem Analysemodell verwendet, um diesen Bericht zu erstellen. Die Daten sind normalisiert, was zu einer Verzögerung bei der Verfügbarkeit der Quelle führen kann.

PaketDatenZeitrahmenBeispiel US-Quelle *
Finanzdaten des Unternehmens10 Jahre
  • Gewinn- und Verlustrechnung
  • Kapitalflussrechnung
  • Bilanz
Konsensschätzungen der Analysten+3 Jahre
  • Finanzielle Vorausschau
  • Kursziele der Analysten
Marktpreise30 Jahre
  • Aktienkurse
  • Dividenden, Splits und Aktionen
Eigentümerschaft10 Jahre
  • Top-Aktionäre
  • Insiderhandel
Verwaltung10 Jahre
  • Das Führungsteam
  • Direktorium
Wichtige Entwicklungen10 Jahre
  • Ankündigungen des Unternehmens

* Beispiel für US-Wertpapiere, für nicht-US-amerikanische Wertpapiere werden gleichwertige regulatorische Formulare und Quellen verwendet.

Sofern nicht anders angegeben, beziehen sich alle Finanzdaten auf einen Jahreszeitraum, werden aber vierteljährlich aktualisiert. Dies wird als Trailing Twelve Month (TTM) oder Last Twelve Month (LTM) Daten bezeichnet. Erfahren Sie mehr.

Analysemodell und Schneeflocke

Details des Analysemodells, das zur Erstellung dieses Berichts verwendet wurde, sind auf unserer GitHub-Seite verfügbar. Außerdem haben wir Leitfäden zur Nutzung unserer Berichte und Tutorials auf YouTube.

Erfahren Sie mehr über das Weltklasse-Team, das das Simply Wall St-Analysemodell entworfen und entwickelt hat.

Metriken für Industrie und Sektor

Unsere Branchen- und Sektionskennzahlen werden alle 6 Stunden von Simply Wall St berechnet. Details zu unserem Verfahren finden Sie auf Github.

Analysten-Quellen

Jenoptik AG wird von 18 Analysten beobachtet. 9 dieser Analysten hat die Umsatz- oder Gewinnschätzungen übermittelt, die als Grundlage für unseren Bericht dienen. Die von den Analysten übermittelten Daten werden im Laufe des Tages aktualisiert.

AnalystEinrichtung
Peter RothenaicherBaader Helvea Equity Research
Volker BosseBaader Helvea Equity Research
Lasse StuebenBerenberg